NetraMark Holdings Inc. (AINMF)

Compare

1.0400

+0.0790

+(8.22%)

At close: April 4 at 3:39:27 PM EDT

Key Events

Advanced Chart

Loading Chart for AINMF

Previous Close 0.9610
Open 0.9728
Bid 1.0500 x 40000
Ask 1.0800 x 40000
Day's Range 0.9728 - 1.0400
52 Week Range 0.1140 - 1.2500
Volume 1,000
Avg. Volume 5,880
Market Cap (intraday) 87.779M
Beta (5Y Monthly) 2.02
PE Ratio (TTM) --
EPS (TTM) -0.0400
Earnings Date --
Forward Dividend & Yield --
Ex-Dividend Date --
1y Target Est --

NetraMark Holdings Inc. develops artificial intelligence and machine learning solutions for the pharmaceutical industry in Canada. The company's product suite comprises Netra Shatter; Netra Health Atlas; and NetraAi that is designed to help interact and explore with different perspective of the data for clinical trials. It provides NetraPlacebo module that analyzes past trial data to determine what drives placebo responses to guide inclusion/exclusion criteria; and Netra GPT module that offers insights from past clinical trials about the patient's population by utilizing established medical literature. The company was formerly known as Nurosene Health Inc. and changed its name to NetraMark Holdings Inc. in February 2023. The company was founded in 2016 and is headquartered in Toronto, Canada.

www.netramark.com

Full Time Employees

September 30

Fiscal Year Ends

Healthcare

Sector

Health Information Services

Industry

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

AINMF

45.25%

S&P/TSX Composite index (^GSPTSE)

5.80%

1-Year Return

AINMF

438.02%

S&P/TSX Composite index (^GSPTSE)

5.18%

3-Year Return

AINMF

158.06%

S&P/TSX Composite index (^GSPTSE)

5.02%

5-Year Return

AINMF

22.96%

S&P/TSX Composite index (^GSPTSE)

79.26%

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

AINMF

NetraMark Holdings Inc.

1.0400

+8.22%

Mkt Cap 87.779M